NovaBridge Biosciences Ratios (2018-2025) | NBP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Dec2018	Sep2019	Dec2019	Jun2020	Sep2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Jun2023	Sep2023	Dec2023	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
EBT Margin (Quarter)		-1,640.29%				5,920.12%					-17,332.08%	-2,609.84%	-738,200.00%
EBIT Margin (Quarter)		-2,042.94%				5,927.05%					-7,578.62%	-3,375.87%	-789,260.00%
EBITDA Margin (Quarter)		-2,042.94%				5,927.05%					-7,578.62%	-3,375.87%	-789,260.00%
Operating Margin (Quarter)		-2,042.94%									-7,578.62%	-3,375.87%	-789,260.00%
Net Margin (Quarter)		-1,640.29%				5,851.40%					0.20%	10,557.46%
FCF Margin (Quarter)						5,637.19%
Efficiency
Inventory Average (Quarter)									2.14B	0.01B
Assets Average (Quarter)				0.27B	0.46B	0.79B	0.95B	0.91B	0.81B	0.66B	0.53B				0.24B	0.22B	0.21B	0.21B	0.24B	0.27B
Invested Capital (Quarter)	0.01B		0.01B							0.00B	0.00B		0.00B
Asset Utilization Ratio (Quarter)										0.01	0.01
Leverage & Solvency
Interest Coverage Ratio (Quarter)		-25.70	47.72		504.15	854.96							-0.24		-53.97	-56.66		-1.54	-0.47	-288.14
Debt Ratio (Quarter)	0.03		0.03							0.00	0.01		0.01
Times Interest Earned (Quarter)		-25.70	47.72		504.15	854.96							-0.24		-53.97	-56.66		-1.54	-0.47	-288.14
Valuation
Enterprise Value (Quarter)	-0.27B	-0.18B	-0.17B	-0.22B	-0.43B	-0.72B	-0.74B	-118.35B	-0.59B	-0.49B	-0.42B		-0.32B	-0.21B	-0.18B	-0.17B	-0.17B	-0.17B	-0.23B	-0.21B
Return Ratios
Return on Sales (Quarter)		-0.16%				0.60%					2.13%	0.79%	0.30%
Return on Capital Employed (Quarter)						12,521.82%					20,274.44%				-33.49%	-24.01%	-23.73%	-19.04%	-15.37%	-38.94%
Return on Assets (Quarter)				0.00%	0.00%	0.00%	0.00%	0.00%	0.00%		0.00%				0.00%	0.00%	0.00%	0.00%	0.00%	0.00%